STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
Jian Wang(Shandong Provincial Hospital), Jinming Gao(Southwestern Medical Center)
Cited by 5
Related Papers
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
|Nature Communications|2022|384
Prolonged activation of innate immune pathways by a polyvalent STING agonist
|Nature Biomedical Engineering|2021|298
STING licensing of type I dendritic cells potentiates antitumor immunity
|Science Immunology|2024|110
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
|EMBO Molecular Medicine|2019|82